Lisa M. Kaminskas

5.3k total citations · 1 hit paper
91 papers, 4.3k citations indexed

About

Lisa M. Kaminskas is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Polymers and Plastics. According to data from OpenAlex, Lisa M. Kaminskas has authored 91 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 29 papers in Pulmonary and Respiratory Medicine and 24 papers in Polymers and Plastics. Recurrent topics in Lisa M. Kaminskas's work include Inhalation and Respiratory Drug Delivery (26 papers), Dendrimers and Hyperbranched Polymers (23 papers) and RNA Interference and Gene Delivery (21 papers). Lisa M. Kaminskas is often cited by papers focused on Inhalation and Respiratory Drug Delivery (26 papers), Dendrimers and Hyperbranched Polymers (23 papers) and RNA Interference and Gene Delivery (21 papers). Lisa M. Kaminskas collaborates with scholars based in Australia, United Kingdom and United States. Lisa M. Kaminskas's co-authors include Christopher J. H. Porter, Ben J. Boyd, Victoria M. McLeod, Natalie L. Trevaskis, Brian D. Kelly, Michelle P. McIntosh, David J. Owen, Gemma M. Ryan, Philip Burcham and Simon M. Pyke and has published in prestigious journals such as Nature Reviews Drug Discovery, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Lisa M. Kaminskas

91 papers receiving 4.2k citations

Hit Papers

From sewer to saviour — targeting the lymphatic system to... 2015 2026 2018 2022 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa M. Kaminskas Australia 38 1.6k 926 887 806 737 91 4.3k
Olivia M. Merkel Germany 46 3.8k 2.3× 1.2k 1.3× 927 1.0× 491 0.6× 693 0.9× 147 5.9k
Uday B. Kompella United States 54 2.8k 1.7× 1.1k 1.2× 482 0.5× 274 0.3× 2.0k 2.7× 195 8.0k
Kazem Nejati‐Koshki Iran 32 2.5k 1.5× 1.9k 2.1× 327 0.4× 432 0.5× 826 1.1× 72 6.1k
Silvia Arpicco Italy 36 2.1k 1.3× 2.2k 2.4× 272 0.3× 290 0.4× 730 1.0× 115 4.8k
Swati Biswas India 39 2.8k 1.7× 2.5k 2.7× 411 0.5× 537 0.7× 463 0.6× 151 6.0k
Meena Jaggi United States 51 3.7k 2.3× 2.1k 2.3× 598 0.7× 229 0.3× 728 1.0× 151 8.1k
Shigeru Kawakami Japan 50 4.7k 2.9× 1.4k 1.5× 296 0.3× 413 0.5× 540 0.7× 221 6.9k
Hervé Hillaireau France 28 1.7k 1.0× 1.4k 1.5× 341 0.4× 171 0.2× 652 0.9× 50 3.5k
Franco Dosio Italy 36 2.1k 1.3× 1.8k 2.0× 249 0.3× 202 0.3× 607 0.8× 102 5.0k
Ambikanandan Misra India 44 2.7k 1.6× 2.0k 2.2× 966 1.1× 272 0.3× 3.2k 4.3× 166 7.6k

Countries citing papers authored by Lisa M. Kaminskas

Since Specialization
Citations

This map shows the geographic impact of Lisa M. Kaminskas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Kaminskas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Kaminskas more than expected).

Fields of papers citing papers by Lisa M. Kaminskas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Kaminskas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Kaminskas. The network helps show where Lisa M. Kaminskas may publish in the future.

Co-authorship network of co-authors of Lisa M. Kaminskas

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Kaminskas. A scholar is included among the top collaborators of Lisa M. Kaminskas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Kaminskas. Lisa M. Kaminskas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murray, Margaret, Christopher K. Barlow, Lisa M. Kaminskas, et al.. (2023). Demonstrating a link between diet, gut microbiota and brain: 14C radioactivity identified in the brain following gut microbial fermentation of 14C-radiolabeled tyrosine in a pig model. Frontiers in Nutrition. 10. 1127729–1127729. 4 indexed citations
2.
Chan, Linda J., Fei Huang, Judith A. Scoble, et al.. (2021). Poly(HPMA-co-NIPAM) copolymer as an alternative to polyethylene glycol-based pharmacokinetic modulation of therapeutic proteins. International Journal of Pharmaceutics. 608. 121075–121075. 9 indexed citations
3.
Marasini, Nirmal, Changkui Fu, Nicholas L. Fletcher, et al.. (2020). The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats. Nanomaterials. 10(12). 2452–2452. 10 indexed citations
4.
Kaminskas, Lisa M., Douglas E. V. Pires, & David B. Ascher. (2019). dendPoint: a web resource for dendrimer pharmacokinetics investigation and prediction. Scientific Reports. 9(1). 15465–15465. 37 indexed citations
5.
Patra, Malay, Stefano Ferrari, Paulina D. Ramírez-García, et al.. (2018). Linker chemistry dictates the delivery of a phototoxic organometallic rhenium(i) complex to human cervical cancer cells from core crosslinked star polymer nanoparticles. Journal of Materials Chemistry B. 6(47). 7805–7810. 9 indexed citations
6.
McLeod, Victoria M., Cameron J. Nowell, Laura I. Selby, et al.. (2018). Distribution of therapeutic proteins into thoracic lymph after intravenous administration is protein size-dependent and primarily occurs within the liver and mesentery. Journal of Controlled Release. 272. 17–28. 17 indexed citations
7.
Pires, Douglas E. V., Lisa M. Kaminskas, & David B. Ascher. (2018). Prediction and Optimization of Pharmacokinetic and Toxicity Properties of the Ligand. Methods in molecular biology. 1762. 271–284. 89 indexed citations
8.
Haque, Shadabul, Michael R. Whittaker, Michelle P. McIntosh, et al.. (2018). A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the 3H-labelled structural lipids after pulmonary delivery in rats. European Journal of Pharmaceutics and Biopharmaceutics. 125. 1–12. 46 indexed citations
9.
Ryan, Gemma M., Victoria M. McLeod, Dharmini Mehta, et al.. (2017). Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site. Nanomedicine Nanotechnology Biology and Medicine. 13(8). 2485–2494. 21 indexed citations
10.
Marasini, Nirmal, Shadabul Haque, & Lisa M. Kaminskas. (2017). Polymer-drug conjugates as inhalable drug delivery systems: A review. Current Opinion in Colloid & Interface Science. 31. 18–29. 74 indexed citations
11.
Khor, Song Yang, Jinming Hu, Victoria M. McLeod, et al.. (2016). The Pharmacokinetics and Biodistribution of a 64 kDa PolyPEG Star Polymer After Subcutaneous and Pulmonary Administration to Rats. Journal of Pharmaceutical Sciences. 105(1). 293–300. 18 indexed citations
12.
Sou, Tomás, David Morton, Mark Williamson, et al.. (2015). Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(5). 361–371. 38 indexed citations
13.
McLeod, Victoria M., Linda J. Chan, Gemma M. Ryan, Christopher J. H. Porter, & Lisa M. Kaminskas. (2015). Optimal PEGylation can Improve the Exposure of Interferon in the Lungs Following Pulmonary Administration. Journal of Pharmaceutical Sciences. 104(4). 1421–1430. 27 indexed citations
14.
Kaminskas, Lisa M., Victoria M. McLeod, Gemma M. Ryan, et al.. (2014). Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. Journal of Controlled Release. 183. 18–26. 141 indexed citations
15.
Caliph, Suzanne M., David M. Shackleford, David B. Ascher, & Lisa M. Kaminskas. (2014). Practical Lessons in Murine Thoracic Lymph Duct Cannulations: Observations in Female and Male Mice Across Four Different Strains That Impact on “Cannulatability”. Journal of Pharmaceutical Sciences. 104(3). 1207–1209. 3 indexed citations
16.
Kaminskas, Lisa M., et al.. (2013). The Lymphatic System Plays a Major Role in the Intravenous and Subcutaneous Pharmacokinetics of Trastuzumab in Rats. Molecular Pharmaceutics. 11(2). 496–504. 43 indexed citations
17.
Kaminskas, Lisa M., Brian D. Kelly, Victoria M. McLeod, et al.. (2011). Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. Journal of Controlled Release. 152(2). 241–248. 97 indexed citations
18.
Sou, Tomás, et al.. (2011). Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach. International Journal of Pharmaceutics. 421(2). 220–229. 50 indexed citations
19.
Kaminskas, Lisa M., Zhiyuan Wu, Νicholas Barlow, et al.. (2009). Partly-PEGylated Poly-L-lysine Dendrimers Have Reduced Plasma Stability and Circulation Times Compared With Fully PEGylated Dendrimers. Journal of Pharmaceutical Sciences. 98(10). 3871–3875. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026